1. History and mission
Regenerative medicine is one of the most dynamic areas of research in the biomedical research and is of central importance for the development of translational medicine. The aim of regenerative medicine is the restoration of dysfunctional cells, tissues or organs by stimulating the body's own repair or regeneration processes or by biological replacement of tissue engineered living cells, tissues or biomaterials in the laboratory.
In 2015, biotechnet and the NTN SwissBiotech founded a novel platform dedicated to regenerative medicine. The mission of this new platform "Translational and Clinical Bio-Manufacturing" (in order to sharpen its activities and competencies the name of the platform has been redefined from "Regenerative Medicine" towards "Translational and Clinical Bio-Manufacturing" in 2017) is to bundle the existing expertise of regenerative medicine activities in Switzerland with a focus on the translation from the pre-clinical phase towards therapeutic biomedical applications. Networking activities facilitated through the platform "Translational and Clinical Bio-Manufacturing" will lead to novel research co-operations between academic patrners. Together, we endeavor to innovate regenerative medicine development on the academic level.
2. Platform members
The platform is led by Dr. Steffen M. Zeisberger and has multiple (inter-)national industrial and academic collaboration partners.
2.1 How to become a platform partner
To become a platform member, please contact Dr. Steffen M. Zeisberger for details. The partnership fee is CHF 500.- p.a..
Currently one membership application has been received and is pendent:
- Plattform for Stem Cell Research in Regenerative Medicne (SCRM) http://www.stemcellsbern.ch/wb/pages/intropage.php
3. Events and News
Please visit events and news on this homepage